logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Identifying Novel Inborn Errors Of The Immune System Primary Immunodeficiencies With Defective Class Switch And Autoimmunity 1st Edition Elisabeth Salzer Auth

  • SKU: BELL-5740654
Identifying Novel Inborn Errors Of The Immune System Primary Immunodeficiencies With Defective Class Switch And Autoimmunity 1st Edition Elisabeth Salzer Auth
$ 31.00 $ 45.00 (-31%)

4.7

36 reviews

Identifying Novel Inborn Errors Of The Immune System Primary Immunodeficiencies With Defective Class Switch And Autoimmunity 1st Edition Elisabeth Salzer Auth instant download after payment.

Publisher: Springer
File Extension: PDF
File size: 3.13 MB
Pages: 91
Author: Elisabeth Salzer (auth.)
ISBN: 9783658167950, 9783658167967, 3658167955, 3658167963
Language: English
Year: 2017
Edition: 1

Product desciption

Identifying Novel Inborn Errors Of The Immune System Primary Immunodeficiencies With Defective Class Switch And Autoimmunity 1st Edition Elisabeth Salzer Auth by Elisabeth Salzer (auth.) 9783658167950, 9783658167967, 3658167955, 3658167963 instant download after payment.

In her study Elisabeth Salzer describes three novel monogenic diseases. For CD27 deficiency Elisabeth Salzer describes a large cohort of patients. Although all patients shared the same causative missense mutation, they displayed diverse clinical presentations. In another patient she was able to identify a mutation in PRKCD resulting in a primary immunodeficiency with severe Lupus-like autoimmunity. The patient exhibited increased mRNA levels of IL6. Therefore, treatment with Tocilizumab, a humanized anti-IL-6 receptor monoclonal antibody was suggested. In a family with a history of deaths due to inflammatory bowel disease she identified a missense mutation in IL21. She produced wild type and mutated IL-21 protein and demonstrated a loss of function phenotype. As IL-21 is in clinical trials, she proposed a potentially curative treatment option. These discoveries contributed to the understanding of the multifaceted regulatory mechanisms of the immune system and highlighted essential players in these complex signaling networks.

Related Products